EFTA01492769.pdf

FINANCIAL TRUST COMPANY INC ACCT. W23560001 For the Period 2/1/12 to 2/29/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized GainLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc Price Quantity Value Original Cost Gaintoss Accrued Div. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 14.35 18,535.000 237,277.25 251,475.52 (14,198.27) 04033A-10-0 ARIA BIOGEN [DEC INC 116.47 2,095.000 244,004.65 250,454.95 (6,450.30) 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 86.52 1,003.000 000 865,200.00 1,000,000.00 (134,80000) 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07,15,11 MS 21 09 2515A1-A7-6 P FIRST REPUBLIC BANK SAN FRAN 29.99 000 33616C-I0-0 FRC HSBC MARKET PLUS SPX 05/17/13 100.03 5,000,000.000 5,001,500.00 5,003,000.00 1,500.00 72% KO BARRIER- 0%CPN ,UNCAPPED INITIAL LEVEL-02/14/12 SPX:1350.50 4042K1-X0-1 P ONEOK PARTNERS LP 58.20 0.00 4.19% 682613N-10-3 OKS JP Morgan Account W23560001 Page 5 of 33 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan JPM-SDNY-00015582 Chase CONFIDENTIAL SDNY_GM_00284780 EFTA01492769